A New Challenging Strategy in the Prevention and Management of Tumor Lysis Syndrome in Patients with Chemo-Sensitive Hematological Malignancies
Introduction. Tumor lysis syndrome (TLS) is a metabolic derangement that results from rapid destruction of cells. It happens frequently in cancers receiving chemotherapy, particularly hematological malignancies. It can lead to death in severe cases. Tumor lysis syndrome that leads to acute renal fai...
Main Authors: | Ammar ELJack, Mohamad El Abdallah, Kadhim Al-Banaa, Kashif Chaudhry, Faisal Musa |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/3740547 |
Similar Items
-
Tumor Lysis Syndrome in Patients with Hematological Malignancies
by: Yohannes Belay, et al.
Published: (2017-01-01) -
Hematological malignancies presenting as spontaneous tumor lysis syndrome: A case series
by: Shehla Basheer Kollathodi, et al.
Published: (2018-01-01) -
Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies
by: McBride Ali, et al.
Published: (2012-12-01) -
The Challenge of Targeting Notch in Hematologic Malignancies
by: Fiorela N Hernandez Tejada, et al.
Published: (2014-06-01) -
Tumor lysis syndrome in childhood malignancies
by: Wing Lum Cheung, et al.
Published: (2020-02-01)